Mobile-game developers are supercharging old tools with new tech to keep players hooked. Increasingly, the biggest money ...

Vermont Business Magazine A team of northern New England universities and institutions led by the University of Vermont (UVM) ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for ...

LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular ...

In December 2025, FDA announced that it was deploying agentic AI capabilities across the agency. FDA defined these systems as ...

Discover how a new Stanford study reveals surprising, personalized blood sugar responses—and why fiber, potatoes, or grapes ...

MRH, a 13MP monochrome USB camera product built on the Onsemi AR1335 back-side-illuminated CMOS sensor. The module pairs ...

Learn more about eLife assessments Mosquito-borne virus transmission is increasing globally. Due to a lack of effective vaccines or targeted treatments, mitigation relies on reducing human exposure to ...

An in vivo small-molecule drug screen in developing zebrafish larvae identifies dozens of unique chemical modulators capable of reducing atherogenic apolipoprotein B levels.

A company that pays for work expects to own all of it, and until recently, with appropriate terms and conditions in place, it did.

Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...